SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-024557
Filing Date
2022-05-06
Accepted
2022-05-06 16:47:22
Documents
14
Period of Report
2022-05-02
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea159471-8ka1_enzobio.htm   iXBRL 8-K/A 29359
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENZO BIOCHEM, INC ea159471ex3-1_enzobiochem.htm EX-3.1 59595
3 AMENDED AND RESTATED BY-LAWS OF ENZO BIOCHEM, INC ea159471ex3-2_enzobiochem.htm EX-3.2 91533
  Complete submission text file 0001213900-22-024557.txt   395458

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20220502.xsd EX-101.SCH 3018
5 XBRL LABEL FILE enz-20220502_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE enz-20220502_pre.xml EX-101.PRE 22586
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159471-8ka1_enzobio_htm.xml XML 4795
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 001-09974 | Film No.: 22901985
SIC: 8071 Services-Medical Laboratories